New liver stent aims to tame deadly cirrhosis complications

NCT ID NCT06669806

Recruiting now Disease control Sponsor: C. R. Bard Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a special stent called LIVERTY TIPS, placed in the liver to create a new pathway for blood flow in people with cirrhosis and high blood pressure in the liver. The goal is to see if it can keep the new channel open and reduce problems like bleeding or fluid buildup. About 166 adults with cirrhosis and related complications will be followed for 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TIPS stent graft (a mesh tube placed in the liver to create a new blood flow channel)
What this could lead to: If successful, this stent could offer a safer, more effective way to manage serious complications of cirrhosis, reducing the need for repeat procedures.
What could go wrong: This is an early-stage, single-arm study with no comparison group, so results may not be definitive. Risks include stent blockage, infection, or worsening liver function.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASCITES HEPATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver esophageal varices with bleeding portal hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASCITES HEPATIC PORTAL HYPERTENSION RELATED TO CIRRHOSIS VARICEAL BLEEDING

Contacts and locations

Locations

Hunan Provincial People's Hospital
RECRUITING

Changsha, Hunan, 410005, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.